-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LMpaSRXJjJOn8JGjkG/xq4QSCnlSHOcZNxLH5MMZIXKEETo3eQFSwSgsrlJlpc78 tnM8PLkSDgr+g1eZVzv79w== 0001179110-11-003305.txt : 20110223 0001179110-11-003305.hdr.sgml : 20110223 20110223190816 ACCESSION NUMBER: 0001179110-11-003305 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110220 FILED AS OF DATE: 20110223 DATE AS OF CHANGE: 20110223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Winningham Rick E CENTRAL INDEX KEY: 0001302443 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 11633652 MAIL ADDRESS: STREET 1: 901 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0303 4 2011-02-20 0 0001080014 THERAVANCE INC THRX 0001302443 Winningham Rick E THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Executive Officer Common Stock 2011-02-20 4 F 0 6790 22.50 D 422033 D Common Stock 2011-02-22 4 M 0 11729 8.525 A 433762 D Common Stock 2011-02-22 4 M 0 246411 8.525 A 680173 D Common Stock 2011-02-22 4 S 0 158500 21.43 D 521673 D Common Stock 2011-02-22 4 S 0 10300 22.15 D 511373 D Common Stock 2011-02-23 4 M 0 142500 8.525 A 653873 D Common Stock 2011-02-23 4 S 0 97600 21.14 D 556273 D Stock Option (Right to Buy) 8.525 2011-02-22 4 M 0 11729 0 D 2011-12-08 Common Stock 11729 0 D Stock Option (Right to Buy) 8.525 2011-02-22 4 M 0 246411 0 D 2011-12-08 Common Stock 246411 516052 D Stock Option (Right to Buy) 8.525 2011-02-23 4 M 0 142500 0 D 2011-12-08 Common Stock 142500 373552 D Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c). This transaction was executed in multiple trades at prices from $21.00 to $21.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices from $22.00 to $22.36. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices from $20.71 to $21.43. The price reported above reflects the weighted average sale price. Immediately exercisable Bradford J Shafer as Attorney-in-Fact 2011-02-23 -----END PRIVACY-ENHANCED MESSAGE-----